Staying the course The RBNZ left the OCR at 5.5%. The forward profile was lowered, and now implies around a 40% chance of a further OCR increase (down from 75% previously) and is in line Read more…
New Zealand central bank, RBNZ maintained its OCR at 5.50% but surprised markets with lower OCR forecasts for 2024 and 2025. A less hawkish RBNZ has triggered a sell-off in the Kiwi (-1% intraday against Read more…
CADJPY cycle from 2.1.2024 low is in progress as a nesting 5 waves. Up from 2.1.2024 low, wave ((i)) ended at 111.407 and pullback in wave ((ii)) ended at 110.6. Pair resumes higher in wave Read more…
DXY: The DXY chart currently exhibits a bearish momentum. However, price could rise towards the 1st resistance before resuming a potential bearish continuation towards the 1st support. The 1st resistance level at 104.09 is identified Read more…
Key Highlights Bitcoin price extended its rally above $53,200 and $55,000. BTC cleared a major declining channel with resistance at $51,850 on the 4-hour chart. Ethereum also rallied above the $3,150 and $3,200 resistance levels. Read more…
The Monthly CPI Indicator rose 3.4% in the year to January, in line with the outcome recorded in December. This remains the equal softest print for monthly inflation estimate since November 2021. The January print Read more…
Fed Governor Michelle Bowman articulated that Fed is “not at that point” to initiate rate cuts. Additionally, she expressed readiness to increase rates further if progress on inflation “has stalled or reversed”. “Should the incoming Read more…
Australia monthly CPI was unchanged at 3.4% yoy in January, below expectation of a rise to 3.6% yoy. CPI excluding volatile items and holiday travel slowed from 4.2% yoy to 4.1% yoy. Trimmed mean CPI Read more…
The OCR remains at 5.5%. The RBNZ’s monetary policy strategy remains unchanged, implying the OCR will remain at 5.5% until 2025 – in line with Westpac’s forecasts. The OCR remains at 5.5%. The RBNZ reduced Read more…
Philips is on the cutting edge of healthcare innovation with a wide range of medical devices and products. Roy Jakobs, CEO, Royal Philips, joined TheStreet to discuss which Philips products he’s most excited about as Read more…